Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression

Clinical trial NCT05373680 · COMPLETED

Trial details

NCT number: NCT05373680
Sponsor: Tanta University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Renal Insufficiency, Chronic

Start date: 2022-01-01
Primary completion: 2024-04-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.